key: cord-0981559-jpbzbbvo
authors: Aghili, Seyed Morsal Mosallami; Ebrahimpur, Mahbube; Arjmand, Babak; Shadman, Zhaleh; Pejman Sani, Mahnaz; Qorbani, Mostafa; Larijani, Bagher; Payab, Moloud
title: Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis
date: 2021-02-26
journal: Int J Obes (Lond)
DOI: 10.1038/s41366-021-00776-8
sha: 11c9c41763178ce125e6bb50f7d6164ca6270aab
doc_id: 981559
cord_uid: jpbzbbvo

BACKGROUND: Recent studies have shown that obesity is associated with the severity of coronavirus disease (COVID-19). We reviewed clinical studies to clarify the obesity relationship with COVID-19 severity, comorbidities, and discussing possible mechanisms. MATERIALS AND METHODS: The electronic databases, including Web of Science, PubMed, Scopus, and Google Scholar, were searched and all studies conducted on COVID-19 and obesity were reviewed. All studies were independently screened by reviewers based on their titles and abstracts. RESULTS: Forty relevant articles were selected, and their full texts were reviewed. Obesity affects the respiratory and immune systems through various mechanisms. Cytokine and adipokine secretion from adipose tissue leads to a pro-inflammatory state in obese patients, predisposing them to thrombosis, incoordination of innate and adaptive immune responses, inadequate antibody response, and cytokine storm. Obese patients had a longer virus shedding. Obesity is associated with other comorbidities such as hypertension, cardiovascular diseases, diabetes mellitus, and vitamin D deficiency. Hospitalization, intensive care unit admission, mechanical ventilation, and even mortality in obese patients were higher than normal-weight patients. Obesity could alter the direction of severe COVID-19 symptoms to younger individuals. Reduced physical activity, unhealthy eating habits and, more stress and fear experienced during the COVID-19 pandemic may result in more weight gain and obesity. CONCLUSIONS: Obesity should be considered as an independent risk factor for the severity of COVID-19. Paying more attention to preventing weight gain in obese patients with COVID-19 infection in early levels of disease is crucial during this pandemic.

In December 2019, coronavirus disease 2019 (COVID- 19) caused by SARS-CoV-2 infection has been emerged in Wuhan, China, and has spread rapidly and caused a global health crisis. By November 15, 2020, 53,766,728 confirmed identified. Finally, 55 articles were included in the study, and the full texts of the articles were reviewed. The characteristics of the included clinical trials and reasons behind the exclusion are summarized in Table 1 .

All cohort, cross-sectional, descriptive, and retrospective studies were included in the study. Most countries that have conducted the studies on COVID-19 and obesity are China, the United States, Italy, UK, and France.

We learned from the H1N1 Influenza epidemic that obesity is associated with more hospitalization, comorbidities, mechanical ventilation, and death [19, 20] . An increasing body of evidence shows that obesity influences severity and outcomes of COVID-19 (Table 1) . A recent report released by the Intensive Care National Audit & Research Centre has shown that 39.3% of 9949 critically ill COVID-19 patients were obese, higher than the prevalence of 31.8% in the British age-and sex-matched general population. Also, the hazard ratio in survival analysis increased slightly above 1, when BMI rose above 30 kg/m 2 [21] .

Other studies also had similar results. A study conducted on 4103 COVID-19 patients in New York considered BMI > 40 kg/m 2 as the most significant predictor of hospitalization after age [16] . Moreover, a study performed on 383 patients in China showed that obese patients had a 2.42-fold increased risk of severe pneumonia compared to normalweight patients, even after adjusting for potential confounders [22] . Furthermore, Hajifathalian et al. [23] in a study conducted on 770 COVID-19 patients in New York found that patients with obesity were more likely to present overt symptoms and have twofold increased risk of ICU admission or death compared to normal-weight patients. Also, one study from China established that 88.24% of COVID-19 non-survivors had a BMI > 25 kg/m 2 [24] .

Mechanical ventilation, in addition to ICU admission, is considered as one of the most important indicators of severe disease. A small study in Seattle showed that 85% of obese patients need the mechanical ventilation [25] . Other studies confirmed the higher need for mechanical ventilation in obese patients. A study of 124 COVID-19 patients admitted in the ICU in a university hospital in Lille, France, reported a 7.36fold need for intubation in patients with BMI > 35 (85.7% of them) compared to those with BMI < 25 kg/m 2 , independent of other comorbidities. Obesity (BMI ≥ 30) and severe obesity (BMI ≥ 35) were found in 47.6% and 28.2% of cases [17] . However, the results of another study in Lyon, France, were different. This study reported a lower prevalence of obesity and mechanical ventilation as compared to the Lille study. These differences may occur due to lower obesity prevalence in the Lyon area and different treatment protocols. However, the mechanical ventilation requirement was higher in obese patients (BMI ≥ 35 kg/m 2 ) compared to lean patients (81.8 vs. 41 .9%) [26] . Also, another study on 92 patients with COVID-19-associated pneumonia in Italy demonstrated that obesity is linked to a higher requirement of assisted ventilation (mechanical or noninvasive ventilation) and ICU admission, as two important indicators of disease severity, after adjusting for other variables. This study reported intensive or semi-intensive respiratory unit admission and mortality in 41.3 and 47.4% of obese patients. However, in this study, obese patients did not show significantly higher mortality rates [27] .

Obesity could lead to severe COVID-19 both in young and old patients, but obesity in elderly individuals may be accompanied by more comorbidities, for example, obesity is associated with type-2 diabetes mellitus (T2DM) that is seen frequently in those aged 65 years [28] . Relative fat mass increases and muscle mass decreases in older individuals, even in nonobese ones, especially in patients with respiratory and cardiac diseases [29] . It was furthermore shown that risk of ICU admission in obese patients is higher than that in lean individuals across all age groups [23] .

However, a study in New York showed that younger people with COVID-19 admitted to the ICU were obese [30] . Similarly, another study in New York demonstrated that people with a BMI between 30 and 34 kg/m 2 and >35 kg/m 2 were 1.8 and 3.6 times more likely to be admitted to the ICU, respectively. [18] . Moreover, in an Italian study, obese patients were~9 years younger than normal-weight patients and needed more assisted ventilation and intensive or semi-intensive care [27] . It is essential to note that obesity may increase the chance of severe COVID-19 disease in younger individuals, especially in populations with high obesity prevalence.

Adipose tissue, as a viral reservoir, could make the virus shedding longer in obese patients. This pattern was also seen in influenza infection. More specifically this disease in obese patients was more contagious due to more prolonged shedding of virus [31] , a lower interferon level [32] , and a positive relationship of obesity with the virus load in exhaled air [33] . Viral shedding is also prolonged in obese patients due to impaired immune response, particularly reduced macrophage activation and impaired B-and T-cell responses [34] .

Many countries face a heavy burden of the COVID-19 pandemic on the health care system. Obesity and the heavy burden associated with COVID-19 have a two-sided relationship. Obese patients require more ICU beds [23] , and due to the pandemic, many ICU beds are occupied. On the contrary, a high prevalence of obesity among a population could lead to the lack of ICU beds. Also, shortage of bariatric beds and the difficulty of positioning and transportation make more burden on nurses and other health care workers [7, 35] . Furthermore, appropriate requirements for obese patients are frequently scarce in many hospitals, e.g., computed tomography (CT) machines that are not able to accommodate obese patients' weights. Besides these weight limits on CT machines, diagnosis based on pulmonary ultrasound is more difficult in obese patients, and these challenges make an early diagnosis more difficult in obese patients [36] . Also, difficult intubation due to additional adipose tissue on the larynx and difficult insertion of catheters are other factors that make managing obese patients so challenging [35, 36] .

Effects of obesity on the respiratory system

There are many hypotheses about the mechanism of how obesity affects COVID-19 (Fig. 1) . It is not surprising that obese patients have many respiratory complications if infected with SARS-CoV-2. Obesity could affect the respiratory system in various ways. Previous studies have confirmed that obesity is a risk factor for many respiratory system diseases like asthma, obstructive sleep apnea syndrome, acute lung injury, and ARDS [37] . Frequently, there are alterations in the respiratory system and chest wall physiology of obese individuals due to fat deposits in the mediastinum and abdomen. Reduced chest wall elasticity, limited truncal expansion, low respiratory muscle strength, and limited diaphragm excursion predispose these individuals to lower respiratory system compliance with a decrease in expiratory reserve volume [10, 28, 38] . Obesity is associated with increased airway resistance, impaired gas exchange, positional gas trapping, and surfactant dysfunction [38, 39] . These functional and physiological changes predispose them to hypoventilation-associated pneumonia, pulmonary HTN, and cardiac stress [25] .

Moreover, the impaired ventilation of the base of the lungs in obese patients could result in reduced oxygen saturation of the blood [40] . Lower lung zones have higher perfusion due to gravity; however, these zones are not well-ventilated because obese individuals' functional residual capacity is near their residual volume [41] [42] [43] . This ventilation-perfusion mismatch could lead to lower partial pressure of oxygen (PO2) [40] . Furthermore, obese patients require more oxygen consumption to reach this lower PO2 [44] ; thus, more oxygen requirement and hypoxia in obese patients could lead to the exacerbation of problems in oxygenation.

Obesity could impair the immune system in various ways. From past experiences, we know that antibody response to influenza vaccine was reduced in obese individuals, and their infection risk was double than that of lean individuals [32, 45] . Moreover, in animal studies, the severity and duration of viral infection were increased in obese animals [32] . Also, obesity is an independent risk factor for an immune-mediated disease like psoriasis [46] . A balance between cytokines is necessary for an appropriate immune response. However, a pro-inflammatory state in obese patients disrupts this essential balance. This state may be due to the inappropriate secretion of adipokines and cytokines like tumor necrosis factor, interleukin-6 (IL-6), and C-reactive protein by adipocytes in hypoxic conditions [47, 48] . A previous study has shown that IL-6 is an independent risk factor for developing severe COVID-19 [49] , and adipose tissue is one of the primary sources of IL-6 secretion [50] . The creation of an autoregenerating inflammation loop in this pro-inflammatory state by recruitment of immune cells (macrophages, T cells, and B cells) impairs the immune system [48] . In this status, a viral infection could simply start an impaired immune response, leading to a cytokine storm by overproduction of pro-inflammatory cytokines. The cytokine storm could lead to vascular hyperpermeability and multiorgan failure seen in severe cases of COVID-19 [51] . In the human model, studies have shown that IL-6 is responsible for the activation of multiple cytokine pathways in this pro-inflammatory state [52] .

Obesity could lead to the incoordination of innate and adaptive immune responses by disruption of lymphoid tissue integrity and alterations in leukocyte development and activity [36] . In particular, the impairment of CD8+ memory T cells was seen in obese patients vaccinated for influenza and considered as the leading cause of their weak antibody response to the vaccine [53] . A decrease in macrophage activation due to pro-inflammatory status was regarded as another cause of this inadequate response [34, 53] . Also, memory T-cell impairment could lead to more tissue damage during viral infection challenge [54] . Furthermore, a study in Wuhan showed that patients with severe COVID-19 had less memory, and regulatory T cells [22] .

Leptin Leptin is an adipose tissue-derived cytokine that signals the body to stop caloric consumption [35] . Also, leptin plays an essential role in the maturation, development, and function of B lymphocytes [55] . Leptin function in obese individuals is impaired. Surprisingly, leptin serum levels were very high in obese patients due to leptin resistance, like insulin resistance in T2DM [35] , and this leptin resistance was associated with disease severity in H1N1 influenza [55] .

Complement system The complement system is inappropriately activated in obese patients [56] . This overreaction is one of the possible mechanisms of the impaired immune reaction to SARS-CoV-2. In a study conducted on SARS-CoV, C3 deficient mice had better respiratory function and a lower level of IL-6 [57] .

Dipeptidyl peptidase-4 (DDP4) Furthermore, a high level of DDP4 in obese patients is another possible mechanism of immune system impairment. DDP4 is a transmembrane enzyme in human adipose tissue and has an association with obesity-related T2DM [58] . DDP4 inhibition led to GLP-1 increasing and improved insulin sensitivity in adipose tissue [59] . Even in nonobese patients, DDP4 inhibition could suppress pro-inflammatory cytokines like IL-6 and IL-10 [60] .

Visceral adipose tissues like epicardial fat tissue and ectopic fat tissue in the alveolar space may play a significant role in severe disease by expressing a high level of angiotensinconverting enzyme 2 (ACE-2) receptors. SARS-CoV-2 has a high affinity to bind the ACE-2 receptors [61] . This receptor is expressed in many organs and tissue, particularly lung tissue [62] . However, adipose tissue has a higher level of ACE-2 expression than lung tissue [63] . Obese patients have more adipose tissue than lean individuals, resulting in more ACE-2 receptors.

Obesity could accompany other COVID-19 severity risk factors like T2DM, cardiovascular disease, and kidney diseases [25] (Fig. 2) . In diabetic and obese patients, insulin resistance due to excess fat could lead to inadequate metabolic response to immunologic challenge and more insulin requirement during COVID-19 severe infection [29] .

Even in the absence of other comorbidities, HTN, dyslipidemia, and insulin resistance could increase the risk of cardiovascular events in obese patients infected with SARS-CoV-2 [25] . Left ventricular (LV) hypertrophy due to HTN is the most common cardiac morphology change [64, 65] . In addition, the hyperactivity of the renin-angiotensin-aldosterone system in obese patients could affect myocardium by increasing levels of angiotensin II [66] . Furthermore, obesity could lead to right ventricular dysfunction as an issue in COVID-19 patients due to higher circulating plasma volume [51] . Also, LV diastolic dysfunction and heart failure are common in obese patients [64, 65, 67] . Moreover, the pro-inflammatory state in obese patients may increase the risk of thrombosis by creating an imbalance of procoagulant and anticoagulant factors, increasing thrombin generation, and enhancing platelet activation [68, 69] . Recently, in some patients with severe COVID-19 infection, a generalized thrombotic microvascular injury was observed in pulmonary and cutaneous biopsy and autopsy samples [70] . Vitamin D deficiency is another possible risk factor for developing severe COVID-19 [71] . Vitamin D as an immunomodulator plays an essential role in decreasing the production of pro-inflammatory cytokines [72] . About 40-80% of the obese population is vitamin D deficient [72] due to volumetric dilution, sequestration of vitamin D in adipose tissue, and negative feedback from 1,25-dihydroxy vitamin D [73] . Also, in the ICU, obese patients with malnutrition have worse outcomes than those without malnutrition [74] . Moreover, increasing the need for calorie consumption due to a severe acute inflammatory state in SARS-CoV-2 infection could provoke malnutrition [28] .

Adipose tissues in each part of the body could play a role in the severity of COVID-19. For example, abdominal obesity is linked to the impaired ventilation, particularly in the supine state, by reducing diaphragmatic excursion [75] . There are two layers of adipose tissue in the abdomen: visceral and subcutaneous. Abdominal visceral fat is associated with T2DM, HTN, and cardiovascular disease [76] ; however, a similar prevalence of T2DM to the USA in China may relate to more visceral and ectopic adipose tissue instead of abdominal fat in patients of Asian descent [7] .

Visceral adipose tissue, either abdominal or nonabdominal, is responsible for a pro-inflammatory state by abnormal adipokine and cytokine secretion [54, 77] . This state makes visceral adipose tissue capable of driving inflammation in organs (such as heart, liver, kidney, and lungs) and also leads to immune response impairment [54] . Moreover, adipose tissue expresses a high level of ACE-2 receptors, and this may ease the local spreading of the virus in visceral intrathoracic (lungs), epicardial (heart), and perirenal (kidney) adipose tissue [54] . H5N1 viral tropism has been shown for adipose tissue [78] . Also, adipose tissue is capable of more influenza virus shedding [31] . Moreover, visceral adipose tissue is one of the main sources of IL-6 secretion, and higher levels of IL-6 are associated with more mortality in SARS-CoV-2 [4] .

Epicardial adipose tissue is another visceral fat tissue associated with increased BMI. This fat tissue could decrease myocardial function, in addition to adipokines secretion. Also, a high level of ACE-2 receptors in epicardial fat tissue could increase the risk of myocarditis in obese COVID-19 patients [79] .

How COVID-19 lead to more obesity?

Social distancing during COVID-19 pandemic in many countries leads to significant changes in the individuals' lifestyle. Decreasing activity, changing eating habits, sleep disorders, stress, and experiencing fear are some significant changes in people's lives that may result in weight gain and obesity. Reduced level of daily physical activity may be due to the lockdown and keeping schools, gym, and parks closed, teleworking, depression, and fear.

On the other hand, stress and anxiety in people experiencing bad news may result in weight gain [80] . Stress could result in weight gain by cortisol release (activation of the hypothalamo-adrenal-pituitary axis) [81] and more fat and sweet food consumption (activation of reward centers in the brain) [82] . Also, stress is associated with sleep disruption and lower physical activity, resulting in weight gain [83] .

Changing the diet to canned food due to food insecurity and fresh food unavailability, eating high-caloric snacks or junk foods during other activities and eating food late at night are unhealthy eating habits during the COVID-19 lockdown [81, 83] . These eating habits have more carbohydrate, fat, and sodium, and also processed food could lead to more food consumption by addictive-like behaviors. Furthermore, inadequate sleep may alter the circadian rhythm of hormones and immune system efficacy [83] .

Moreover, self-isolation and depression are frequent in obese individuals due to weight stigma [84] . During the lockdown, there were lots of fat-shaming memes on social media [85] , and this content could lead to more isolation.

Depression or stigmatizing may lead to delay in referring to health care centers in obese patients [86] .

In 17 studies, meta-analysis demonstrated that obesity (BMI ≥ 30) was associated with poor outcome (OR: 1.297 [1.178-1.416], p < 0.001; I 2 : 0.0%, heterogeneity = 13.69) (Fig. 3A) .

In six studies, meta-analysis demonstrated that obesity (BMI ≥ 30) was not associated with ICU admission and obesity did not significantly increase the ICU admission (OR: 1.189 [0.955-1.424], I 2 : 0.0%, heterogeneity = 1.92) (Fig. 3B ).

In eight studies, meta-analysis suggested that in patients hospitalized with COVID-19, obesity (BMI ≥ 30) was associated with invasive mechanical ventilation (OR: 2.049 [1.420-2.678], I 2 : 75.3%, heterogeneity = 28.34) (Fig. 3C ).

Ten retrospective cohort studies reported the effect of obesity on the mortality. Meta-analysis demonstrated that obesity (BMI ≥ 30) was associated with mortality and obesity increased mortality (OR: 1.35 [1.241-1.459], I 2 : 76.6%, heterogeneity = 38.44) (Fig. 3D) .

Because of obesity effects on COVID-19, weight gain prevention is highly recommended during the pandemic. Changing lifestyle has been found to play an important role in the prevention of weight gain. Increased physical activity and exercise at home or outdoors with social distancing are critical ways to prevent weight gain in normal-weight people and also lose weight in overweight or obese individuals. Exercise also could improve the metabolic and immunologic functions of the body [87] . Creative methods to do exercise more at home and high activity games with children may lead to more activity despite limitations. Reduced high-caloric food consumption is another feasible way to prevent weight gain. Increased fresh food and decreased canned and junk food consumption are notable points that should be considered during the pandemic. Moreover, psychological support and treatment or medical interventions to control stress and avoid emotional eating, and also, sleep regulation could also be useful to reach this goal.

In addition to these recommendations, obese patients should consider a steady low-caloric diet and proven weight loss drugs (synthetic or herbal drugs under physician observation) to lose weight due to their increased risk of disease [88, 89] . Furthermore, obese patients who have diabetes should tightly control their glycemic status and adjust their medication and calorie consumption with these new circumstances. As a result, telemedicine could play a crucial role in the close monitoring of obese patients during COVID-19 pandemic.

Obesity affects the respiratory and immune systems through various mechanisms. Cytokine and adipokine secretion from adipose tissue leads to a pro-inflammatory state in obese patients, and this predisposes them to thrombosis, incoordination of innate and adaptive immune responses, inadequate antibody responses, and cytokine storm. Also, viral shedding is more in obese patients. Obesity is associated with other comorbidities such as HTN, cardiovascular disease, diabetes mellitus, and vitamin D deficiency.

Hospitalization, ICU admission, mechanical ventilation, and even mortality in obese patients are higher than normalweight people. It seems obesity could shift severe COVID- 19 symptoms to younger individuals. Also, early diagnosis and management of obese patients are harder than those of lean individuals. Decreasing activity, changing eating habits and, more stress and fear experienced during the COVID-19 pandemic may result in more weight gain and obesity. More attention to weight gain prevention is necessary during this pandemic.

Obesity should be considered as an independent risk factor for developing severe COVID-19. We recommend that clinicians consider more serious treatments in the early stages of disease for obese patients.

Reviewing all relevant studies conducted on "Obesity and COVID-19" and various possible mechanisms were the strength of this study. However, we have some limitations such as full-text unavailability for some non-English studies and lack of cohort studies. Most of the studies were crosssectional and retrospective and also some had small sample sizes; we recommend that prospective cohort studies be conducted on larger sample sizes.

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention

Clinical course and risk factors for mortality of adult inpatients with

China: a retrospective cohort study

Coronavirus disease (COVID-19): 10 questions and discussion points for diabetes and COVID-19

Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19

COVID 19 and the Patient with Obesity -The Editors Speak Out

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study

Health effects of overweight and obesity in 195 countries over 25 years

A medieval medical view on obesity

Back to the future: lessons learned from the 1918 influenza pandemic

Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease

Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A metaanalysis

Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission

Risk factors for 2009 pandemic influenza A (H1N1)-related hospitalization and death among racial/ethnic groups in New Mexico

Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California

Intensive Care National Audit Research Centre. ICNARC report on COVID-19 in critical care 19

Obesity and COVID-19 severity in a designated hospital in Shenzhen

Obesity is associated with worse outcomes in COVID-19: analysis of early data from

Epidemiological, clinical, radiological characteristics and outcomes of medical staff with COVID-19 in Wuhan, China: a single-centered, retrospective case series analysis

Obesity and impaired metabolic health in patients with COVID-19

Obesity is associated with severe forms of COVID-19

Obesity and COVID-19: an Italian snapshot

COVID-19 and endocrine diseases. A statement from the

Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms

Obesity could shift severe COVID-19 disease to younger ages

Obesity increases the duration of influenza a virus shedding in adults

Obesity-related microenvironment promotes emergence of virulent influenza virus strains

Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community

The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology

SARS-CoV-2 infection and obesity: common inflammatory and metabolic aspects

Comentary: obesity: the "achilles heel" for COVID-19? Metab Exp

Obesity and SARS-CoV-2: a population to safeguard

Obesity and respiratory diseases

Altered respiratory physiology in obesity

The effect of obesity on lung function

The effects of body mass index on lung volumes

Chest mechanics in morbidly obese non-hypoventilated patients

Physiologic correlates of dyspnea in patients with morbid obesity

Tissue oxygenation in obese and non-obese patients during laparoscopy

Obesity impairs the adaptive immune response to influenza virus

Evidence of a causal relationship between body mass index and psoriasis: a mendelian randomization study

Relationship of obesity and visceral adiposity with serum concentrations of CRP

Inflammation and macrophage modulation in adipose tissues

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Obesity is a positive modulator of IL-6R and IL-6 expression in the subcutaneous adipose tissue: significance for metabolic inflammation

Does coronavirus disease 2019 disprove the obesity paradox in acute respiratory distress syndrome?

Dynamics of a cytokine storm

Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells

Is adipose tissue a reservoir for viral spread, immune activation, and cytokine amplification in coronavirus disease

Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity

Association of serum complement C3 with metabolic syndrome components in normal weight obese women

Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis

Targeting the adipose tissue in COVID-19

COVID-19 and diabetes: can DPP4 inhibition play a role?

DPP4-directed therapeutic strategies for MERS-CoV

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Two things about COVID-19 might need attention

Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome

Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management

Obesity cardiomyopathy: pathogenesis and pathophysiology

Effects of isolated obesity on systolic and diastolic left ventricular function

Mechanisms of thrombosis in obesity

Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases

Evidence that vitamin d supplementation could reduce risk of influenza and covid-19 infections and deaths

The interplay between vitamin D and viral infections

Vitamin D in obesity

The relationship among obesity, nutritional status, and mortality in the critically Ill

Obesity and its implications for COVID-19 mortality

Subcutaneous and visceral adipose tissue: structural and functional differences

Obesity and the risk and outcome of infection

Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice

Obesity accompanying COVID-19: the role of epicardial fat

Exercising in times of COVID-19: what do experts recommend doing within four walls?

Which foods may be addictive? The roles of processing, fat content, and glycemic load

Psychosocial stress is associated with obesity and diet quality in Hispanic/Latino adults

The mutual effects of COVID-19 and obesity

Joint international consensus statement for ending stigma of obesity

European association for the study of obesity position statement on the global COVID-19 pandemic

Weight bias and health care utilization: a scoping review

Hallmarks of improved immunological responses in the vaccination of more physically active elderly females

Development of a novel anti-obesity compound with inhibiting properties on the lipid accumulation in 3T3-L1 adipocytes

Effect of the herbal medicines in obesity and metabolic syndrome: a systematic review and meta-analysis of clinical trials

Epidemiology of Covid-19 in a Long-Term Care Facility in King County

Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia

Epidemiological, clinical characteristics and outcome of medical staff infected with COVID-19 in Wuhan, China: a retrospective case series analysis. medRxiv

Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the

Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV

Early and critical care in severe patients with COVID-19 in Jiangsu Province, China: a descriptive study

COVID-19 in a designated infectious diseases hospital outside Hubei Province

Clinical findings in critical ill patients infected with SARS-Cov-2 in Guangdong Province, China: a multi-center, retrospective, observational study

COVID-19 in a long-term care facility

Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults

Covid-19 in critically ill patients in the Seattle region-case series

Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease

Association of cigarette smoking, obesity, and underlying medical conditions with COVID-19 hospitalization and mortality in Iran: A nationwide retrospective ecological study

Association between clinical manifestations and prognosis in patients with COVID-19

Short-term outcomes in individuals aged 75 or older with severe coronavirus disease (COVID-19): first observations from an infectious diseases unit in Southern Italy

Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui

Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 at a Tertiary Care Medical Center

Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19

The characteristics of 50 hospitalized COVID-19 patients with and without ARDS

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality

Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a crosssectional study

Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease

Association of obesity with disease severity among patients with coronavirus disease 2019

Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

Clinical characteristics of hospitalized individuals dying with COVID-19 by age group in Italy

Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series

Prevalence of obesity among adult inpatients with COVID-19 in France

Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a Children's Hospital

Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico

Obesity and risk of COVID-19: analysis of UK biobank

Clinical features and outcomes of 105 hospitalized patients with COVID-19 in

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study

Risk factors associated with clinical outcomes in 323 coronavirus disease 2019 (COVID-19) hospitalized Patients in Wuhan, China

Factors associated with intubation and prolonged intubation in hospitalized patients With COVID-19

Intensive Care National Audit & Research Centre. ICNARC report on COVID-19 in critical care 04

Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center

Severe obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50

Louisiana Coronavirus COVID-19 | Department of Health | State of Louisiana

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

Association of higher body mass index (BMI) with severe coronavirus disease 2019 (COVID-19) in younger patients

Obesity and mortality of COVID-19. Meta-analysis

Acknowledgements Implementation of this study was sponsored by